Shared Instrumentation Grant for Purchase of a Nikon N-SIM/N-STORM Super-Resoluti
Shared Instrumentation Grant for Purchase of a Nikon N-SIM/N-STORM Super-Resoluti
批准号:
8447655
负责人:
KEN-ICHI TAKEMARU
金额:
$60.0万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-06-20 至 2014-06-19
关键词:
BiologicalCellular StructuresConfocal MicroscopyDataDimensionsFundingGrantImageLasersLightingMicroscopeMicroscopyOpticsProteinsProtocols documentationRequest for ProposalsResearch PersonnelResolutionSpecialistStaining methodStainsStructureSystemThickThree-Dimensional ImagingTimeUniversitiesbasehuman diseaseinstrumentinstrumentationoperationreconstructionsingle molecule
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This proposal requests funds for the purchase of a Nikon N-SIM/N-STORM Super-Resolution Microscope System. The instrument combines both SIM and STORM systems into one platform. The N-SIM (Structured Illumination Microscopy) achieves a resolution two times higher than that of conventional confocal microscopes in each dimension. It is equipped with 5 laser lines (458/488/515/532/561 nm) and capable of 3D imaging up to 20 ¿m thickness. The N-STORM (Stochastic Optical Reconstruction Microscopy) is a single-molecule localization-based microscope that generates a dramatically enhanced resolution that is ten times (approx. 20 nm laterally) higher than confocal microscopy in all three
axes. The N-STORM comes equipped with a 4-laser illumination unit (405/488/561/647 nm) and 3D STORM capability. Currently, there is no super-resolution microscope available at Stony Brook University. The system will facilitate the spatial resolution of protein localization and cellular structures beyond the diffraction limit of ~200nm, enabling investigators to explore fundamental biological problems related to human disease at high precision. Management and operation of the system will be provided by a technical specialist, who will also assists users in developing staining and imaging protocols for special projects, as well as helping investigators in the analysis of super-resolution data. )
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
The Role of Chibby Family Members in Spermatogenesis and Male Fertility
-
批准号:10656017
-
项目类别:
-
资助金额:$41.75万
-
财政年份:2023
-
负责人:KEN-ICHI TAKEMARU
-
依托单位:
Trafficking and Sorting Mechanisms of Golgi Vesicles to Cilia
-
批准号:10161782
-
项目类别:
-
资助金额:$34.79万
-
财政年份:2020
-
负责人:KEN-ICHI TAKEMARU
-
依托单位:
Trafficking and Sorting Mechanisms of Golgi Vesicles to Cilia
-
批准号:10612805
-
项目类别:
-
资助金额:$34.79万
-
财政年份:2020
-
负责人:KEN-ICHI TAKEMARU
-
依托单位:
Trafficking and Sorting Mechanisms of Golgi Vesicles to Cilia
-
批准号:10379375
-
项目类别:
-
资助金额:$34.79万
-
财政年份:2020
-
负责人:KEN-ICHI TAKEMARU
-
依托单位:
Chibby and Wnt Signaling in Ciliated Cell Differentiation
-
批准号:8085306
-
项目类别:
-
资助金额:$39.01万
-
财政年份:2011
-
负责人:KEN-ICHI TAKEMARU
-
依托单位:
Chibby and Wnt Signaling in Ciliated Cell Differentiation
-
批准号:8264752
-
项目类别:
-
资助金额:$39.01万
-
财政年份:2011
-
负责人:KEN-ICHI TAKEMARU
-
依托单位:
Chibby and Wnt Signaling in Ciliated Cell Differentiation
-
批准号:8442395
-
项目类别:
-
资助金额:$42.8万
-
财政年份:2011
-
负责人:KEN-ICHI TAKEMARU
-
依托单位:
Chibby and Wnt Signaling in Ciliated Cell Differentiation
-
批准号:8644869
-
项目类别:
-
资助金额:$44.07万
-
财政年份:2011
-
负责人:KEN-ICHI TAKEMARU
-
依托单位:
Chibby and Wnt Signaling in Ciliated Cell Differentiation
-
批准号:8515598
-
项目类别:
-
资助金额:$3.72万
-
财政年份:2011
-
负责人:KEN-ICHI TAKEMARU
-
依托单位:
Role of Beta-Catenin Antagonist Chibby in Adipogenesis
-
批准号:7175401
-
项目类别:
-
资助金额:$32.93万
-
财政年份:2006
-
负责人:KEN-ICHI TAKEMARU
-
依托单位:
Role of Beta-Catenin Antagonist Chibby in Adipogenesis
-
批准号:7288066
-
项目类别:
-
资助金额:$2.62万
-
财政年份:2006
-
负责人:KEN-ICHI TAKEMARU
-
依托单位:
Role of Beta-Catenin Antagonist Chibby in Adipogenesis
-
批准号:7014894
-
项目类别:
-
资助金额:$28.42万
-
财政年份:2006
-
负责人:KEN-ICHI TAKEMARU
-
依托单位:
Role of Beta-Catenin Antagonist Chibby in Adipogenesis
-
批准号:7573462
-
项目类别:
-
资助金额:$27.15万
-
财政年份:2006
-
负责人:KEN-ICHI TAKEMARU
-
依托单位:
Role of Beta-Catenin Antagonist Chibby in Adipogenesis
-
批准号:7340160
-
项目类别:
-
资助金额:$29.77万
-
财政年份:2006
-
负责人:KEN-ICHI TAKEMARU
-
依托单位:
海外基金